Key Facts
Type
Organization
Sector
Not specified
Industry
Not specified
Status
Draft
Country
Not specified
Headquarters
Not specified
Founded
Not specified
Dissolved
Active
Website
Email
investor.relations@allergan.com
Phone
+1-862-261-7000
Also Known As
No alternate names
Tags
No tags
Overall Confidence
95%
Internal Notes
No notes
Key Information
Leadership
No leadership added
Positions
No positions added
About
Allergan plc was an Irish-domiciled pharmaceutical company that was the target of a hostile takeover bid by Valeant Pharmaceuticals and Pershing Square Capital Management in 2014. Elliott Management was a significant shareholder during the takeover battle.
Key Relationships
Paul Singer
defended
In 2014, Paul Singer's Elliott Management played a key role in defending Allergan plc against a hostile takeover bid by Valeant Pharmaceuticals and Pershing Square Capital Management. Elliott, which owned a significant stake in Allergan, supported the company's legal and strategic efforts to fend off the takeover, including the use of a 'poison pill' defense and litigation to challenge Valeant's bid. Elliott's involvement was critical in Allergan's eventual decision to pursue a white knight acquisition by Actavis (now Allergan) in 2015.
Since 2014